Jie You

1.6k citations
40 papers · 1.0k indexed · h-index 17
Topics
Liver Disease Diagnosis and Treatment (8 papers)Hepatocellular Carcinoma Treatment and Prognosis (5 papers)Cancer, Lipids, and Metabolism (5 papers)
Partner nations
ChinaUnited KingdomItaly

In The Last Decade

Jie You

39 papers receiving 1.0k citations

Peers

Jie You
Comparison fields: 5 of 96
  • Surgery 376
  • Oncology 257
  • Epidemiology 227
  • Physiology 213
  • Hepatology 167
Replace Satoshi Ikei with:
Satoshi Ikei Japan
Masamichi Baba Japan
B. Isaksson Sweden
Yao‐Li Chen Taiwan
Hideko Ohama Japan
Xiaofei Wang China
Hyun Ju Kim South Korea
A Cavallaro Italy
Ponnandai Somasundar United States
Hennie G. Raterman Netherlands
Jie You relative to Satoshi Ikei Japan Satoshi Ikei's profile →
Citations per field
00.5×7.2×
Satoshi Ikei · 1×
Citations per year

Countries citing papers authored by Jie You

Since Specialization
Citations

This map shows the geographic impact of Jie You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie You more than expected).

Fields of papers citing papers by Jie You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie You. The network helps show where Jie You may publish in the future.

Co-authorship network of co-authors of Jie You

This figure shows the co-authorship network connecting the top 25 collaborators of Jie You. A scholar is included among the top collaborators of Jie You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie You. Jie You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 6
4 2
5 0
6 4
7 1
8 50
9 3
10 74
11 22
12 18
13 2
14 9
15 56
16
Effect of Modified Spleen-Fortifying Qi-Boosting Phlegm-Transforming Formula on Lung Cancer Related Fatigue
2
17 97
18 42
19 6
20
Clinical Evaluation of “Feiji Decoction” in Treating Non-small Cell Lung Cancer in 61 Cases
1

About Jie You

Jie You is a scholar working on Hepatology, Cancer Research and Complementary and alternative medicine, having authored 40 papers that have together received 1.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cancer, Lipids, and Metabolism (5 papers). The work is most often cited by research in Hepatology (167 citations), Geriatrics and Gerontology (42 citations) and Cancer Research (158 citations). Jie You has collaborated with scholars based in China, United Kingdom and Italy. Frequent co-authors include Ming‐Hua Zheng, Qiqiang Zeng, Zhengping Yu, Qiyu Zhang, Han Cui, Yacong Bo, Quanjun Lü, Yiwei Zhu, Xueyuan Zhang and Wen‐Yue Liu. Their work appears in journals such as PLoS ONE, IEEE Access and Nutrients.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026